To evaluate the dose-response relationship of a novel recombinant human FSH ( rhFSH ; FE 999049 ) with respect to ovarian response in patients undergoing IVF/intracytoplasmic sperm injection treatment ; and prospectively study the influence of initial antimllerian hormone ( AMH ) concentrations .